-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
WCLC News
-
Media Training Improves Advocacy Reach, Increases Lung Cancer Awareness
LungCAN Co-Chair Dusty Donaldson says training program helped just two advocates reach more than 630 million people in 32 states and five countries.
-
Experts Highlight Advances in Lung Cancer Pathology During World Conference Closing Plenary Session
Drs. Keith Kerr and Sanja Dacic shared findings from the IASLC Pathology Committee, which is investigating how to best assess pathologic response to neoadjuvant immunotherapy in lung cancer.
-
Data Show Certain Reproductive Factors Are Associated with Increased Risk of Lung Cancer in Women
During WCLC 2023, Dr. Yan Zhang presented findings that she says support the inclusion of factors such as early menarche and early menopause in lung cancer screening programs.
-
WCLC Plenary Session Featured Lectureship Award Winners Discussing Range of Issues in Thoracic Oncology
Drs. Wendy Cooper, Melissa Culligan, And Navneet Singh concluded the session with talks on the future of pathology, enhancing the patient experience, and accurate staging in lung cancer.
-
Middle East and Africa Region Earns Bragging Rights with Most Points During 2023 Wellness Challenge
The challenge, Step It Up for Research, helped WCLC 23 attendees stay active during the meeting while raising money to support the IASLC Foundation, which provides grants for research, education, and other scientific initiatives.
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
IASLC Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura and Drs. Valerie Rusch and Enrico Ruffini summarized the data and recommendations in lung cancer, mesothelioma, and thymic cancer.
-
AEGEAN Shows Benefit with the Addition of Perioperative Durvalumab to Neoadjuvant Chemotherapy in Resectable NSCLC
Dr. Tetsuya Mitsudomi, who presented the data at WCLC 2023, said regardless of disease stage, the addition of perioperative durvalumab did not adversely impact the feasibility, type, approach, or timing of surgery for participants in the trial.
-
World Conference Plenary Addresses Barriers to—and Opportunities for—Lung Cancer Care in Low- to Middle-Income Countries
Drs. Mariam Jamal-Hanjani, Alan Sihoe, Anil Tibdewal, and Ross Soo discussed challenges and strategies across the lung cancer spectrum—from early-stage to oligometastatic and advanced disease.
-
Lectureship Award Winners Discuss Broad Thoracic Oncology Topics During WCLC 23 Plenary Session
Honorees Drs. Jessica Donington, Rafal Dziadziuszko, and Jie Wang presented thought-provoking talks on return to treatment after surgery, radiation oncology in Poland, and biomarkers in small cell lung cancer.
-
Inaugural Amazing Case Race Winners Announced
The IASLC Academy’s 2023 cohort spent months leading up to WCLC 2023 crafting case summaries in hopes of winning a spot in the association’s first case-based simulation course.